Elevation Oncology, Inc.
ELEV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $49 | $46 | $146 |
| Short-Term Investments | $44 | $34 | $44 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $5 | $3 | $3 |
| Total Curr. Assets | $95 | $88 | $93 | $149 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | -$0 |
| Total NC Assets | $1 | $1 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $96 | $89 | $94 | $149 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $6 | $6 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $4 | $9 | $3 |
| Total Curr. Liab. | $4 | $4 | $16 | $9 |
| LT Debt | $31 | $30 | $29 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $31 | $30 | $29 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $36 | $34 | $45 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$240 | -$196 | -$150 | -$55 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $300 | $251 | $199 | $196 |
| Total Equity | $60 | $55 | $49 | $141 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $96 | $89 | $94 | $149 |
| Net Debt | -$18 | -$19 | -$16 | -$146 |